Cargando…
RPL35A is a key promotor involved in the development and progression of gastric cancer
BACKGROUND: RPL35A has been reported to work as a biomarker in tumor angiogenesis. However, little work has been performed on the expression level and functional importance of RPL35A in gastric cancer (GC). METHODS: The protein expression level of RPL35A was detected by immunohistochemical staining...
Autores principales: | Wu, Fang, Sun, Dachuan, Liao, Yuqian, Shang, Kai, Lu, Canrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447681/ https://www.ncbi.nlm.nih.gov/pubmed/34535139 http://dx.doi.org/10.1186/s12935-021-02199-x |
Ejemplares similares
-
DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35
por: Zhou, Xin, et al.
Publicado: (2022) -
Ribosomal protein L31 (RPL31) inhibits the proliferation and migration of gastric cancer cells
por: Wu, Fang, et al.
Publicado: (2023) -
Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors
por: Ren, Yanming, et al.
Publicado: (2018) -
RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
por: Shi, Rui, et al.
Publicado: (2022) -
Key elements involved in Epstein–Barr virus-associated gastric cancer and their network regulation
por: Jing, Jing-jing, et al.
Publicado: (2018)